BioMarin Pharmaceutical, Inc. (BMRN)
61.40
+2.89
(+4.94%)
USD |
NASDAQ |
Nov 18, 16:00
61.40
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Price : 61.40 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 57.95 | 58.65 | 57.33 | 58.51 | 2.252M |
| Nov 16, 2026 | 57.59 | 58.84 | 57.11 | 57.99 | 2.021M |
| Nov 13, 2026 | 56.86 | 57.39 | 56.35 | 57.23 | 1.466M |
| Nov 12, 2026 | 58.48 | 58.68 | 56.20 | 56.70 | 1.942M |
| Nov 11, 2026 | 57.10 | 58.38 | 56.90 | 58.33 | 1.659M |
| Nov 10, 2026 | 56.82 | 57.37 | 56.38 | 57.13 | 1.431M |
| Nov 09, 2026 | 56.56 | 57.45 | 54.71 | 57.18 | 2.067M |
| Nov 06, 2026 | 55.25 | 56.08 | 55.00 | 56.03 | 2.733M |
| Nov 05, 2026 | 57.44 | 57.99 | 55.97 | 56.12 | 2.165M |
| Nov 04, 2026 | 56.60 | 57.51 | 55.67 | 57.13 | 3.223M |
| Nov 03, 2026 | 53.06 | 56.33 | 52.00 | 55.66 | 4.699M |
| Nov 02, 2026 | 58.66 | 59.51 | 57.17 | 57.44 | 3.265M |
| Oct 30, 2026 | 58.40 | 59.37 | 57.86 | 58.51 | 2.274M |
| Oct 29, 2026 | 56.58 | 57.51 | 56.29 | 57.49 | 2.618M |
| Oct 28, 2026 | 55.18 | 56.18 | 54.85 | 56.00 | 2.002M |
| Oct 27, 2026 | 55.83 | 56.09 | 55.05 | 55.35 | 2.463M |
| Oct 26, 2026 | 56.50 | 56.89 | 55.34 | 55.75 | 2.361M |
| Oct 23, 2026 | 56.68 | 56.81 | 55.24 | 55.95 | 1.683M |
| Oct 22, 2026 | 55.40 | 56.91 | 55.02 | 56.63 | 2.397M |
| Oct 21, 2026 | 56.40 | 57.00 | 54.91 | 55.21 | 2.506M |
| Oct 20, 2026 | 55.08 | 56.48 | 54.95 | 56.44 | 3.475M |
| Oct 19, 2026 | 54.78 | 55.12 | 54.08 | 54.67 | 2.996M |
| Oct 16, 2026 | 56.32 | 56.53 | 54.44 | 54.68 | 2.628M |
| Oct 15, 2026 | 56.45 | 57.59 | 55.96 | 56.05 | 2.923M |
| Oct 14, 2026 | 54.75 | 55.56 | 54.46 | 55.14 | 1.846M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exelixis, Inc. | 68.24 |
| Ascendis Pharma A/S | 270.31 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| PS Ratio | 3.232 |
| Price to Book Value | 1.901 |
| Price to Free Cash Flow | 21.50 |
| Earnings Yield | -0.17% |
| Market Cap | 11.89B |
| Operating PE Ratio | 16.84 |
| Normalized PE Ratio | 32.18 |